Alva Review-Courier -

FDA approves new, cheaper rival to EpiPen allergy shot


U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical greed.

The Food and Drug Administration on Thursday approved Adamis (ad-DEHM-iss) Pharmaceuticals Corp.'s product, which should go on sale later this year.

Symjepi (sim-JEPP'-ee) is a syringe prefilled with the hormone epinephrine, which helps stop life-threatening allergic reactions from insect stings and bites or eating foods such as nuts and eggs.

San Diego-based Adamis says its product is easier to use than Mylan's EpiPen, an autoinjector that comes...

For access to this article please sign in or subscribe.


Reader Comments


Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020